Get the Stockscreener App
0.6244
13.82%
0.0758
Rani Therapeutics Holdings Inc stock is traded at $0.6244, with a volume of 1.10M.
It is up +13.82% in the last 24 hours and up +42.75% over the past month.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
See More
Previous Close:
$0.5486
Open:
$0.559
24h Volume:
1.10M
Relative Volume:
0.63
Market Cap:
$29.41M
Revenue:
$1.20M
Net Income/Loss:
$-52.41M
P/E Ratio:
-0.6862
EPS:
-0.91
Net Cash Flow:
$-31.25M
1W Performance:
+13.53%
1M Performance:
+42.75%
6M Performance:
-62.39%
1Y Performance:
-79.66%
1-Day Range:
$0.5501
$0.6244
1-Week Range:
$0.52
$0.6244
52-Week Range:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Name
Rani Therapeutics Holdings Inc
Sector
Industry
Phone
(408) 457-3700
Address
2051 RINGWOOD AVENUE, SAN JOSE
Compare RANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.6244 | 26.53M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Initiated | Oppenheimer | Outperform |
| Jun-14-24 | Initiated | Maxim Group | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Oct-11-22 | Initiated | UBS | Buy |
| Jul-27-22 | Initiated | H.C. Wainwright | Buy |
| Jun-13-22 | Initiated | Wedbush | Outperform |
View All
Rani Therapeutics Holdings Inc Stock (RANI) Latest News
Quantitative breakdown of Rani Therapeutics Holdings Inc. recent move2025 Pullback Review & Risk Managed Trade Strategies - Newser
What candlestick patterns are forming on Rani Therapeutics Holdings Inc.July 2025 Trends & Target Return Focused Stock Picks - Newser
Rani Therapeutics Holdings Inc. Bounces Off Moving Average SupportOptions Play & Stock Portfolio Risk Control - mustnews.co.kr
Will Rani Therapeutics Holdings Inc. stock recover after recent drop2025 Fundamental Recap & Verified Short-Term Plans - Newser
Combining machine learning predictions for Rani Therapeutics Holdings Inc.2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Does Rani Therapeutics Holdings Inc. show high probability of rebound2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Is it too late to sell Rani Therapeutics Holdings Inc.July 2025 Trends & Community Consensus Picks - Newser
Is Rani Therapeutics Holdings Inc. forming a bottoming baseJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
What Fibonacci levels say about Rani Therapeutics Holdings Inc. rebound2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
Key metrics from Rani Therapeutics Holdings Inc.’s quarterly dataJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Rani Therapeutics Holdings Inc. stock trend outlook and recovery path2025 Support & Resistance & Safe Entry Zone Tips - Newser
Can you recover from losses in Rani Therapeutics Holdings Inc.Trade Exit Report & Verified Short-Term Trading Plans - Newser
Relative strength of Rani Therapeutics Holdings Inc. in sector analysisShort Setup & Advanced Technical Analysis Signals - Newser
Statistical indicators supporting Rani Therapeutics Holdings Inc.’s strengthEarnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Visual analytics tools that track Rani Therapeutics Holdings Inc. performanceJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Rani Therapeutics Holdings Inc. outperform the marketQuarterly Performance Summary & Fast Moving Trade Plans - Newser
Automated trading signals detected on Rani Therapeutics Holdings Inc.Weekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
What technical models suggest about Rani Therapeutics Holdings Inc.’s comebackMarket Growth Review & Low Risk Entry Point Tips - Newser
What makes Rani Therapeutics Holdings Inc. stock price move sharplyJuly 2025 Trends & Technical Confirmation Alerts - thegnnews.com
Real time scanner hits for Rani Therapeutics Holdings Inc. explainedJuly 2025 Volume & Fast Moving Market Watchlists - Newser
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attention2025 Price Targets & Scalable Portfolio Growth Ideas - Newser
Strategies to average down on Rani Therapeutics Holdings Inc.Profit Target & Risk Controlled Swing Alerts - Newser
Live Chart Scan Detects Wedge Pattern in Rani Therapeutics Holdings Inc.Trade Risk Assessment & Free AI Powered Buy and Sell Recommendations - sundaytimes.kr
Sector Rotation Brings Rani Therapeutics Holdings Inc. Into FocusWeekly Trade Summary & Step-by-Step Swing Trade Plans - mustnews.co.kr
What moving averages say about Rani Therapeutics Holdings Inc.Weekly Gains Report & Low Risk Entry Point Tips - Newser
Has Rani Therapeutics Holdings Inc. found a price floorTake Profit & Weekly High Conviction Trade Ideas - Newser
What does recent volatility data suggest for Rani Therapeutics Holdings Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Rani Therapeutics Holdings Inc.Dividend Hike & Weekly High Return Stock Forecasts - Newser
Rani Therapeutics Reports Q2 2025 Financial Results - TipRanks
Will Rani Therapeutics Holdings Inc. benefit from macro trendsFree Opportunity Map for Daily Stock Trading - Newser
Comparing Rani Therapeutics Holdings Inc. in custom built stock radarsFree Swing Trade Entry With Volume Triggers - Newser
News impact scoring models applied to Rani Therapeutics Holdings Inc.Free Reliable Alerts for Daily Stock Movers - Newser
RANI: Second Quarter Financial Results - MSN
How institutional ownership impacts Rani Therapeutics Holdings Inc. stockMarket Forecast Summary Over Multi-Year Period - Newser
How Rani Therapeutics Holdings Inc. stock performs during market volatilityFree Breakout Momentum Picks With Protection - Newser
Will Rani Therapeutics Holdings Inc. rebound enough to break evenDaily Pattern Analysis with Return Forecast - Newser
Developing predictive dashboards with Rani Therapeutics Holdings Inc. dataShort-Term Price Breakout Signal Analysis - Newser
Rani Therapeutics Holdings Inc Stock (RANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rani Therapeutics Holdings Inc Stock (RANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
| South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):